Related by context. Frequent words. (Click for all words.) 59 pct -#.# 59 NET EARNINGS 57 Expense Income 57 Revenues Increase 57 Expense Ratio 56 BASIC EARNINGS PER SHARE 56 Income Loss Before 56 Segment Profit 55 Interest Expense Net 55 Guides Q4 55 Guides Q3 55 Adjusted Non GAAP 55 INCOME FROM OPERATIONS 55 Guides Q2 55 - Operating [009] 55 -ecoterrorism 55 Income Tax Provision 54 GROSS MARGIN 54 INCOME TAX EXPENSE 54 AFTER YESTERDAY 'S DECLINE 54 Net Charge Offs 54 Income Per Share 54 - Operating [026] 53 - Operating [015] 53 EBITDA Margin 53 Guides Q1 53 -vnunet.com 53 - Operating [004] 53 FROM CONTINUING OPERATIONS 53 OPERATING INCOME 53 Restructuring Charges 53 - Operating [001] 53 Sees FY# EPS 53 Operating Margin 52 Combined Ratio 52 - Jim Clack 52 Sees Q4 52 Efficiency Ratio 52 From Continuing Operations 51 Nonperforming Assets 51 Earnings Per Common Share 51 DILUTED EARNINGS PER SHARE 51 EPS Guidance 51 Sees Q2 51 - Operating [029] 51 Impairment Charges 51 Sees Q1 51 - OCBSO 51 % -#.# pp 51 Q4 Profit Declines 51 Planning Customer Relationship 51 Gross Profit Margin 50 + - + - [006] 50 Administrative Expense 50 -CSMMU 50 - Total [003] 50 Consolidated Adjusted EBITDA 50 Total Operating Expenses 50 - Total [007] 50 Q1 Profit Declines 50 -JUNCTION 50 OPERATING INCOME LOSS 50 Q1 Profit Rises 50 Earnings Loss Per 50 Adjusted EBITDA Margin 50 Sees Q3 50 - Operating [012] 50 Unallocated corporate 50 2Q Profit Falls 50 Diluted Earnings Per Share 50 CONTINUING OPERATIONS 50 Non GAAP Adjustments 49 Income Tax Expense 49 Q2 Profit Declines 49 -CLOSURE 49 - Operating [020] 49 Payout ratio 49 PER COMMON SHARE 49 = [005] 49 1Q Profit Rises 49 Bimini Capital 49 4Q Profit Up 49 Net Income Loss 49 Fully taxable 48 Operating Income Loss 48 Its ROA 48 4Q Profit Falls 48 2Q Profit Rises 48 Q2 Profit Rises 48 2Q Profit Up 48 Taxable equivalent adjustment 48 Net Income Attributable 48 - Operating [005] 48 Diluted Share 48 Gross Margin 48 Noninterest Expense 48 - Total [001] 47 = [002] 47 1Q Profit Up 47 NINE MONTHS ENDED SEPTEMBER 47 Specialty Pharmaceutical